The DIOXXACT Trial(Diurnal IOP and OBF Xalatan vs Xalatan And Cosopt Trial)

NCT00957190 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Eye Disease

Interventions

DRUG: Dorzolamide 20 mg and Timolol 5 mg

Sponsor

Maisonneuve-Rosemont Hospital

Collaborators

[object Object]